Skip Navigation


Rheumatology Advance Access originally published online on September 23, 2006
Rheumatology 2007 46(1):178-179; doi:10.1093/rheumatology/kel322
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
46/1/178    most recent
kel322v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Boulton, J. G.
Right arrow Articles by Bourne, J. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boulton, J. G.
Right arrow Articles by Bourne, J. T.
Related Collections
Right arrow Rheumatoid Arthritis
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Unstable diabetes in a patient receiving anti-TNF-{alpha} for rheumatoid arthritis

J. G. Boulton and J. T. Bourne1

Royal Hallamshire Hospital, Glossop Road, Sheffield, and 1Chesterfield Royal Hospital Foundation Trust, Chesterfield, UK.

Correspondence to: John Boulton, Specialist Registrar, Department of Rheumatology, Royal Hallamshire Hospital, Sheffield. E-mail: jgboulton@btinternet.com

The first 10% of the full text of this article appears below.

SIR, Tumour necrosis factor-{alpha} (TNF-{alpha}) is a cytokine well-recognized as having a significant role in the inflammatory process. Recent advances have led to the production of drugs that inhibit the action of TNF-{alpha}, producing significant improvement in the control of rheumatic diseases [1]. TNF-{alpha} may also play a role in other physiological . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Arch DermatolHome page
J.-J. Wu and T.-F. Tsai
Recurrent Hyperglycemia During Adalimumab Treatment in a Patient With Psoriasis
Arch Dermatol, October 1, 2008; 144(10): 1403 - 1404.
[Full Text] [PDF]